Tzamal Biopharma is active in a selected no. of therapeutic areas including: Cardiology, Gynecology and Fertility, Oncology, Haemato-Oncology, Anti-infective, , Bone Marrow Transplantation, Endocrinology and Blood effecting drugs  – in many cases with a higher market share in Israel as compared to any other country worldwide.

Tzamal Biopharma is equipped for success in the Israeli market, specifically in the healthcare and bio-pharma areas thanks to the collaborative ties with the Israeli major players, Ministry of Health and Health Care organizations and their various institutes.

The network of contacts serves as a powerful resource based on professional ties and mutual collaborations, which have spanned across several decades.

Tzamal Biopharma is as well highly experienced in the generic field – through registration of selected generic /biosimilar products in Israel after a thorough assessment of R&D barriers, patents, regulations and prices – and offers a comprehensive platform for importing and selling generic/biosimilar products in Israel.

Success in achieving and maintaining leading market share for generic/biosimilar  products has been proven time and time again.